Morbimortality profile by COVID-19 in telework and on-site work in an oil and gas company in Brazil.

BACKGROUND: As a reflection of the health emergency caused by COVID-19, many countries adopted guidelines, which included activity restrictions. As a result, some companies maintained their activities with on-site work and telework. OBJECTIVE: Analyzing the morbidity and mortality profile due to COVID-19 of workers in telework and on-site work in an oil and gas company. METHODS: Cross-sectional, quantitative, and analytical study that included 8,394 workers diagnosed with COVID-19 at an oil and gas company in Brazil, from June 2020 to June 2021. The company's Surveillance Program database was used as an information source. RESULTS: The total prevalence of cases was 21.7% . For teleworking and face-to-face workers, they were 20.7% and 23.3%, respectively. There was a predominance of women (19.7%), white ethnicity/colour (64.7%), higher level position (52.6%), age group over 40 years (36.7%), married (53, 8%), working at the company for a period that ranges from 7 to 10 years (17%), administrative activity (68.5%), and a higher number of symptomatic workers and deaths in telework compared to on-site work. CONCLUSIONS: The results suggest that testing is important to refrain the virus spread in the company's work environments, as it allowed asymptomatic workers to be diagnosed with COVID-19. The study suggested that on-site work was not a transmission facilitator in the occupational environment, which points out the importance of preventive measures in the workplace and the adoption of remote work for the largest possible number of workers to improve the safety of employees, workers who remained in the on-site work modality.

Food and nutrition actions to face Noncommunicable Diseases from the perspective of Primary Health Care in Brazil: a scoping review / Ações de alimentação e nutrição para o enfrentamento das Doenças Não Transmissíveis na perspectiva da Atenção Primária à Saúde no Brasil: uma revisão de escopo

Introdução: as Doenças Não Transmissíveis (DNT) são consideradas um grande problema de saúde pública, o que torna fundamental o desenvolvimento de intervenções de promoção, prevenção e tratamento. Objetivo: sintetizar e avaliar as evidências sobre as ações de alimentação e nutrição para o enfrentamento das DNT em adultos e idosos na perspectiva da APS no Brasil. Método: trata-se de uma revisão de escopo da literatura, guiada pelas diretrizes do JBI e seguida as etapas de Itens de Relatórios Preferenciais para Revisões Sistemáticas e Extensão de Meta-Análises para Revisões de Escopo. A busca ocorreu em 5 bases de dados eletrônicas: MEDLINE, Web of Science, EMBASE, Central Cochrane Library e LILACS, e a literatura cinza, contemplando os sítios eletrônicos oficiais do governo e a Rede de Alimentação e Nutrição do SUS. Resultados: foram identificados um total de 1844 artigos e apenas 42 artigos se enquadraram nos critérios de elegibilidade da metodologia proposta. Foi identificado que entre as evidências científicas disponibilizadas, as ações de alimentação e nutrição na APS, encontram-se concentradas em estratégias de educação e orientação de hábitos saudáveis para tratamento de DNT baseados em Políticas e Diretrizes Públicas de Nutrição designadas em sua maioria por uma população composta de adultos e uma parte reduzida de idosos. Conclusão: há necessidade de mais estudos publicados sobre ações de alimentação e nutrição na APS, pois as evidências científicas disponíveis não correspondem a 50% dos estados brasileiros, sendo insuficientes para impactar positivamente a situação nutricional do país. Além disso, mais pesquisas com abordagem preventiva às DNT são essenciais, uma vez que a APS caracteriza-se por um conjunto de ações relacionadas à saúde que têm como foco principal a promoção e proteção da saúde.

Introduction: Noncommunicable Diseases (NCDs) are considered a major public health problem, which makes it essential to develop interventions for promotion, prevention and treatment. Objective: To synthesize and evaluate the evidence on food and nutrition actions for coping with NCDs in adults and the elderly from the perspective of PHC in Brazil. Methods: This is a literature scoping review, guided by JBI guidelines and following the steps of Preferred Reporting Items for Systematic Reviews and Extended Meta-Analyses for Scoping Reviews. The search took place in 5 electronic databases: MEDLINE, Web of Science, EMBASE, Central Cochrane Library and LILACS, and the gray literature, including the official government websites and the SUS Food and Nutrition Network. Results: A total of 1844 articles were identified and only 42 articles met the eligibility criteria of the proposed methodology. It was identified that, among the available scientific evidence, food and nutrition actions in PHC are concentrated in education strategies and guidance on healthy habits for the treatment of NCD based on Public Nutrition Policies and Guidelines, mostly designated by a population composed of adults and a small proportion of elderly people. Conclusion: there is a need for more studies published on food and nutrition actions in PHC, as the available scientific evidence does not correspond to 50% of the Brazilian states, being insufficient to positively impact the country's nutritional situation. In addition, more research with a preventive approach to NCDs is essential, since PHC is characterized by a set of health-related actions that have as their main focus the promotion and protection of health.

Effect of omega-3 supplementation on the nutritional status of patients with pancreatic cancer: A protocol for systematic review of clinical trials.

BACKGROUND: Globally, pancreatic cancer is the seventh most common cause of cancer-related death in both sexes, accounting for 466,003 deaths and 495,773 new cases in 2020. The purpose of this study was to synthesize and evaluate evidence on the effects of omega-3 supplementation on the nutritional status of patients with pancreatic cancer. METHODS: This systematic review protocol will be guided by Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. Five databases will be searched: MEDLINE/PubMed, CENTRAL Cochrane, EMBASE, Web of Science, and SCOPUS, with no restrictions on the publication date nor language. The internal validity and risk of bias of randomized controlled trials will be assessed using the revised Cochrane Risk-Of-Bias tool for randomized trials (RoB 2), whereas the risk of bias in non-randomized studies of interventions will be evaluated using the ROBINS-I. The heterogeneity among the studies will be assessed using the I2 statistic. Based on the results of this test, we will verify whether the meta-analysis would be feasible. If feasibility would be confirmed, a random-effect model analysis will be performed. For data analysis, the calculation of the pooled effect estimates will have a 95% confidence interval, while the alpha will be set to 0.05 using the R statistical software version 4.0.4. All methodological steps of this review will be performed independently by two reviewers and will be conducted and managed in the EPPI-Reviewer Software™. RESULTS: This review may be of particular interest to researchers and clinicians, given the low survival and overall burden of patients with pancreatic cancer. Furthermore, the results of this systematic review may contribute to the development of new nutritional interventions in these patients. CONCLUSION: To the best of our knowledge, this will be the first study to critically assess the scientific evidence and estimate the effect of omega-3 supplementation on the nutritional status of patients with pancreatic cancer. The review will perform a rigorous approach, adhering to the PRISMA Statement 2020 using a comprehensive and systematic search strategy in five databases and additional sources with no time period nor language restrictions.

Cancer symptom clusters in adult patients undergoing chemotherapy: A systematic review and meta-analysis protocol.

BACKGROUND: In oncology, the prevalence of symptoms is preferentially analyzed in isolation instead of being considered in clusters. However, clinical practice shows that symptoms rarely occur separately but rather form clusters that share common underlying mechanisms in terms of intensity and severity, creating a synergistic effect among them, which can even help predict the development of future symptoms. OBJECTIVE: To identify and gather evidence on the prevalence, composition, severity, and predictors of cancer symptom clusters in adult cancer patients undergoing chemotherapy. METHODS: This systematic review and meta-analysis protocol was developed in compliance with PRISMA-P. Observational and experimental study designs will be included. MEDLINE/PubMed, Cochrane Library, Embase, CINAHL, PsycINFO, Web of Science, Scopus, LILACS, clinical trials.gov-NIH, the British Library, Google Scholar, and preprints [medRXiv] will be searched with no restrictions on idioms, dates, or settings. Two investigators will independently select the studies, perform data extraction, and critically appraise the risk of bias of the included studies. Heterogeneity among the studies will be assessed using the I2 statistic. If meta-analysis was feasible, a random-effect model analysis will be carried out. For data analysis, the pooled effect will be estimated considering 95% confidence interval and α = 5%. In addition, the certainty of evidence will be rated based on Cochrane methods in accordance with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). DISCUSSION: To the best of our knowledge, this systematic review and meta-analysis will be the first to identify and critically assess evidence regarding the prevalence, composition, severity, and predictors of cancer symptom clusters in adult cancer patients undergoing chemotherapy. We intend to provide health professionals with subsidies to reflect on a better understanding of symptom clusters in adult cancer patients, with the aim of contributing to the development of evidence-based therapeutic interventions and success in clinical practice. PROSPERO REGISTRATION NUMBER: CRD42021248406.